SINOMED

SINOMED announced the acquisition of a 72.73% equity interest in U.S.-based eLum Technologies, Inc. for USD 20.73 million, marking its entry into the neurointerventional device market. The transaction gives SINOMED control of approximately 90.91% of eLum.